mt2 receptor Search Results


93
Alomone Labs rabbit anti mt 2 antibody
Rabbit Anti Mt 2 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti mt 2 antibody/product/Alomone Labs
Average 93 stars, based on 1 article reviews
rabbit anti mt 2 antibody - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

94
Bioss mtnr1b polyclonal antibody
Mtnr1b Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtnr1b polyclonal antibody/product/Bioss
Average 94 stars, based on 1 article reviews
mtnr1b polyclonal antibody - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

mt2  (OriGene)
93
OriGene mt2
Fig. 1. Melatonin receptor (MT1 and <t>MT2)</t> overexpression prevented ventral spinal cord 4.1 (VSC4.1) motoneuron death. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h exposure), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-over- expressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50-overexpressed cells + 25 lm LGA (24 h).(A) ApopTag assayshowingrepresentative imagesfromeach treatmentgroup.Arrowsindicateapoptoticcells. (B)Bargraphsindicating the percentage of apoptotic cells (ApopTag assay) and viability (trypan blue dye exclusion test) counted from each group. (C) Representative pictures show levels of MT1, MT2, GPR50, and b-actin levels (Western blotting). (D) Bar graphs indicating the changes in expression of MT1, MT2, and GPR50 over Con [Correction added on 8 Oct 2012, after first online publication: Fig. 1 Panel A has been corrected].
Mt2, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mt2/product/OriGene
Average 93 stars, based on 1 article reviews
mt2 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

90
Neo MPS Inc peptides encompassing the c-tails of the mt 1 and mt 2 receptors
Fig. 1. Melatonin receptor (MT1 and <t>MT2)</t> overexpression prevented ventral spinal cord 4.1 (VSC4.1) motoneuron death. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h exposure), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-over- expressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50-overexpressed cells + 25 lm LGA (24 h).(A) ApopTag assayshowingrepresentative imagesfromeach treatmentgroup.Arrowsindicateapoptoticcells. (B)Bargraphsindicating the percentage of apoptotic cells (ApopTag assay) and viability (trypan blue dye exclusion test) counted from each group. (C) Representative pictures show levels of MT1, MT2, GPR50, and b-actin levels (Western blotting). (D) Bar graphs indicating the changes in expression of MT1, MT2, and GPR50 over Con [Correction added on 8 Oct 2012, after first online publication: Fig. 1 Panel A has been corrected].
Peptides Encompassing The C Tails Of The Mt 1 And Mt 2 Receptors, supplied by Neo MPS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptides encompassing the c-tails of the mt 1 and mt 2 receptors/product/Neo MPS Inc
Average 90 stars, based on 1 article reviews
peptides encompassing the c-tails of the mt 1 and mt 2 receptors - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
GenScript corporation dna sequence of human mt 2 receptor
Fig. 1. Melatonin receptor (MT1 and <t>MT2)</t> overexpression prevented ventral spinal cord 4.1 (VSC4.1) motoneuron death. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h exposure), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-over- expressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50-overexpressed cells + 25 lm LGA (24 h).(A) ApopTag assayshowingrepresentative imagesfromeach treatmentgroup.Arrowsindicateapoptoticcells. (B)Bargraphsindicating the percentage of apoptotic cells (ApopTag assay) and viability (trypan blue dye exclusion test) counted from each group. (C) Representative pictures show levels of MT1, MT2, GPR50, and b-actin levels (Western blotting). (D) Bar graphs indicating the changes in expression of MT1, MT2, and GPR50 over Con [Correction added on 8 Oct 2012, after first online publication: Fig. 1 Panel A has been corrected].
Dna Sequence Of Human Mt 2 Receptor, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna sequence of human mt 2 receptor/product/GenScript corporation
Average 90 stars, based on 1 article reviews
dna sequence of human mt 2 receptor - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Rocha labs melatonin receptors mt1 and mt2
Fig. 1. Melatonin receptor (MT1 and <t>MT2)</t> overexpression prevented ventral spinal cord 4.1 (VSC4.1) motoneuron death. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h exposure), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-over- expressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50-overexpressed cells + 25 lm LGA (24 h).(A) ApopTag assayshowingrepresentative imagesfromeach treatmentgroup.Arrowsindicateapoptoticcells. (B)Bargraphsindicating the percentage of apoptotic cells (ApopTag assay) and viability (trypan blue dye exclusion test) counted from each group. (C) Representative pictures show levels of MT1, MT2, GPR50, and b-actin levels (Western blotting). (D) Bar graphs indicating the changes in expression of MT1, MT2, and GPR50 over Con [Correction added on 8 Oct 2012, after first online publication: Fig. 1 Panel A has been corrected].
Melatonin Receptors Mt1 And Mt2, supplied by Rocha labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/melatonin receptors mt1 and mt2/product/Rocha labs
Average 90 stars, based on 1 article reviews
melatonin receptors mt1 and mt2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Neo MPS Inc peptide affinity chromatography—peptides encompassing the ctails of the mt1 and mt2 receptors
Fig. 1. Melatonin receptor (MT1 and <t>MT2)</t> overexpression prevented ventral spinal cord 4.1 (VSC4.1) motoneuron death. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h exposure), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-over- expressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50-overexpressed cells + 25 lm LGA (24 h).(A) ApopTag assayshowingrepresentative imagesfromeach treatmentgroup.Arrowsindicateapoptoticcells. (B)Bargraphsindicating the percentage of apoptotic cells (ApopTag assay) and viability (trypan blue dye exclusion test) counted from each group. (C) Representative pictures show levels of MT1, MT2, GPR50, and b-actin levels (Western blotting). (D) Bar graphs indicating the changes in expression of MT1, MT2, and GPR50 over Con [Correction added on 8 Oct 2012, after first online publication: Fig. 1 Panel A has been corrected].
Peptide Affinity Chromatography—Peptides Encompassing The Ctails Of The Mt1 And Mt2 Receptors, supplied by Neo MPS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptide affinity chromatography—peptides encompassing the ctails of the mt1 and mt2 receptors/product/Neo MPS Inc
Average 90 stars, based on 1 article reviews
peptide affinity chromatography—peptides encompassing the ctails of the mt1 and mt2 receptors - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
EuroClone mt-2 cell-line expressing cd4- and cxcr4 receptors
Fig. 1. Melatonin receptor (MT1 and <t>MT2)</t> overexpression prevented ventral spinal cord 4.1 (VSC4.1) motoneuron death. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h exposure), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-over- expressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50-overexpressed cells + 25 lm LGA (24 h).(A) ApopTag assayshowingrepresentative imagesfromeach treatmentgroup.Arrowsindicateapoptoticcells. (B)Bargraphsindicating the percentage of apoptotic cells (ApopTag assay) and viability (trypan blue dye exclusion test) counted from each group. (C) Representative pictures show levels of MT1, MT2, GPR50, and b-actin levels (Western blotting). (D) Bar graphs indicating the changes in expression of MT1, MT2, and GPR50 over Con [Correction added on 8 Oct 2012, after first online publication: Fig. 1 Panel A has been corrected].
Mt 2 Cell Line Expressing Cd4 And Cxcr4 Receptors, supplied by EuroClone, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mt-2 cell-line expressing cd4- and cxcr4 receptors/product/EuroClone
Average 90 stars, based on 1 article reviews
mt-2 cell-line expressing cd4- and cxcr4 receptors - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
GeneTex polyclonal rabbit anti-mt2 receptor antiserum
Fig. 1. Melatonin receptor (MT1 and <t>MT2)</t> overexpression prevented ventral spinal cord 4.1 (VSC4.1) motoneuron death. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h exposure), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-over- expressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50-overexpressed cells + 25 lm LGA (24 h).(A) ApopTag assayshowingrepresentative imagesfromeach treatmentgroup.Arrowsindicateapoptoticcells. (B)Bargraphsindicating the percentage of apoptotic cells (ApopTag assay) and viability (trypan blue dye exclusion test) counted from each group. (C) Representative pictures show levels of MT1, MT2, GPR50, and b-actin levels (Western blotting). (D) Bar graphs indicating the changes in expression of MT1, MT2, and GPR50 over Con [Correction added on 8 Oct 2012, after first online publication: Fig. 1 Panel A has been corrected].
Polyclonal Rabbit Anti Mt2 Receptor Antiserum, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit anti-mt2 receptor antiserum/product/GeneTex
Average 90 stars, based on 1 article reviews
polyclonal rabbit anti-mt2 receptor antiserum - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Institute for Clinical Pharmacodynamics female knockout mice with deletions of the melatonin receptors mt1 and mt2
Fig. 1. Melatonin receptor (MT1 and <t>MT2)</t> overexpression prevented ventral spinal cord 4.1 (VSC4.1) motoneuron death. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h exposure), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-over- expressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50-overexpressed cells + 25 lm LGA (24 h).(A) ApopTag assayshowingrepresentative imagesfromeach treatmentgroup.Arrowsindicateapoptoticcells. (B)Bargraphsindicating the percentage of apoptotic cells (ApopTag assay) and viability (trypan blue dye exclusion test) counted from each group. (C) Representative pictures show levels of MT1, MT2, GPR50, and b-actin levels (Western blotting). (D) Bar graphs indicating the changes in expression of MT1, MT2, and GPR50 over Con [Correction added on 8 Oct 2012, after first online publication: Fig. 1 Panel A has been corrected].
Female Knockout Mice With Deletions Of The Melatonin Receptors Mt1 And Mt2, supplied by Institute for Clinical Pharmacodynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/female knockout mice with deletions of the melatonin receptors mt1 and mt2/product/Institute for Clinical Pharmacodynamics
Average 90 stars, based on 1 article reviews
female knockout mice with deletions of the melatonin receptors mt1 and mt2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Servier Laboratories Ltd melatonin mt1 and mt2 receptors
Fig. 1. Melatonin receptor (MT1 and <t>MT2)</t> overexpression prevented ventral spinal cord 4.1 (VSC4.1) motoneuron death. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h exposure), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-over- expressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50-overexpressed cells + 25 lm LGA (24 h).(A) ApopTag assayshowingrepresentative imagesfromeach treatmentgroup.Arrowsindicateapoptoticcells. (B)Bargraphsindicating the percentage of apoptotic cells (ApopTag assay) and viability (trypan blue dye exclusion test) counted from each group. (C) Representative pictures show levels of MT1, MT2, GPR50, and b-actin levels (Western blotting). (D) Bar graphs indicating the changes in expression of MT1, MT2, and GPR50 over Con [Correction added on 8 Oct 2012, after first online publication: Fig. 1 Panel A has been corrected].
Melatonin Mt1 And Mt2 Receptors, supplied by Servier Laboratories Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/melatonin mt1 and mt2 receptors/product/Servier Laboratories Ltd
Average 90 stars, based on 1 article reviews
melatonin mt1 and mt2 receptors - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 1. Melatonin receptor (MT1 and MT2) overexpression prevented ventral spinal cord 4.1 (VSC4.1) motoneuron death. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h exposure), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-over- expressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50-overexpressed cells + 25 lm LGA (24 h).(A) ApopTag assayshowingrepresentative imagesfromeach treatmentgroup.Arrowsindicateapoptoticcells. (B)Bargraphsindicating the percentage of apoptotic cells (ApopTag assay) and viability (trypan blue dye exclusion test) counted from each group. (C) Representative pictures show levels of MT1, MT2, GPR50, and b-actin levels (Western blotting). (D) Bar graphs indicating the changes in expression of MT1, MT2, and GPR50 over Con [Correction added on 8 Oct 2012, after first online publication: Fig. 1 Panel A has been corrected].

Journal: Journal of Pineal Research

Article Title: Overexpression of melatonin membrane receptors increases calcium‐binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms

doi: 10.1111/j.1600-079x.2012.01022.x

Figure Lengend Snippet: Fig. 1. Melatonin receptor (MT1 and MT2) overexpression prevented ventral spinal cord 4.1 (VSC4.1) motoneuron death. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h exposure), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-over- expressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50-overexpressed cells + 25 lm LGA (24 h).(A) ApopTag assayshowingrepresentative imagesfromeach treatmentgroup.Arrowsindicateapoptoticcells. (B)Bargraphsindicating the percentage of apoptotic cells (ApopTag assay) and viability (trypan blue dye exclusion test) counted from each group. (C) Representative pictures show levels of MT1, MT2, GPR50, and b-actin levels (Western blotting). (D) Bar graphs indicating the changes in expression of MT1, MT2, and GPR50 over Con [Correction added on 8 Oct 2012, after first online publication: Fig. 1 Panel A has been corrected].

Article Snippet: After washing with serum-free standard medium (DMEM/F12), motoneurons were transfected in 1% low serum medium [26] over the course of 24 h at 37 C with 35 lL lipofectamine (Life Technologies, Grand Island, NY, USA) and 10 lg of GFP-tagged ORF clone of homosapiens MT1 (MTNR1A: RG210385), MT2 (MTNR1B: RG216445), or GPR50 (RG217839) plasmid (Origene, Rockville, MD, USA).

Techniques: Over Expression, Plasmid Preparation, Expressing, Control, Western Blot

Fig. 2. Overexpression of MT1 and MT2 increases calbindin D28K and parvalbumin for suppressing Ca2+ rise and calpain:calpastatin ratio in ventral spinal cord 4.1 (VSC4.1) cells. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G- protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h exposure), MT1-overexpressed cells + 25 lm LGA (24 h exposure), MT2-overexpressed cells + 25 lm LGA (24 h exposure), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h exposure), GPR50-overexpressed cells + 25 lm LGA (24 h exposure). (A) Determination of intracellular free Ca2+ levels at 24 h. (B) Western blot analysis to show levels of calbindin D28K, parvalbumin, calpain, calpastatin, and b-actin. (C) Bar graphs indicating the changes in expression of calbindin D28K and parvalbumin over Con. (D) Densi- tometric analysis showing the calpain:calpastatin ratio.

Journal: Journal of Pineal Research

Article Title: Overexpression of melatonin membrane receptors increases calcium‐binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms

doi: 10.1111/j.1600-079x.2012.01022.x

Figure Lengend Snippet: Fig. 2. Overexpression of MT1 and MT2 increases calbindin D28K and parvalbumin for suppressing Ca2+ rise and calpain:calpastatin ratio in ventral spinal cord 4.1 (VSC4.1) cells. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G- protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h exposure), MT1-overexpressed cells + 25 lm LGA (24 h exposure), MT2-overexpressed cells + 25 lm LGA (24 h exposure), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h exposure), GPR50-overexpressed cells + 25 lm LGA (24 h exposure). (A) Determination of intracellular free Ca2+ levels at 24 h. (B) Western blot analysis to show levels of calbindin D28K, parvalbumin, calpain, calpastatin, and b-actin. (C) Bar graphs indicating the changes in expression of calbindin D28K and parvalbumin over Con. (D) Densi- tometric analysis showing the calpain:calpastatin ratio.

Article Snippet: After washing with serum-free standard medium (DMEM/F12), motoneurons were transfected in 1% low serum medium [26] over the course of 24 h at 37 C with 35 lL lipofectamine (Life Technologies, Grand Island, NY, USA) and 10 lg of GFP-tagged ORF clone of homosapiens MT1 (MTNR1A: RG210385), MT2 (MTNR1B: RG216445), or GPR50 (RG217839) plasmid (Origene, Rockville, MD, USA).

Techniques: Over Expression, Plasmid Preparation, Expressing, Control, Western Blot

Fig. 3. Overexpression of MT1 and MT2 increase estrogen recep- tor (ERb:ERa) ratio and suppression inflammatory factors in ventral spinal cord 4.1 (VSC4.1) cells. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glu- tamate (LGA) (24 h), 100 nm melatonin (24 h pretreat- ment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-overexpressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50- overexpressed cells + 25 lm LGA (24 h). (A) Western blot anal- ysis to show levels of ERb, ERa, NF-jB, COX-2, and b-actin. (B) Densitometric analysis showing the ERb: ERa ratio. (C) Bar graphs indicating the changes in the expression of NF-jB and COX-2 over Con.

Journal: Journal of Pineal Research

Article Title: Overexpression of melatonin membrane receptors increases calcium‐binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms

doi: 10.1111/j.1600-079x.2012.01022.x

Figure Lengend Snippet: Fig. 3. Overexpression of MT1 and MT2 increase estrogen recep- tor (ERb:ERa) ratio and suppression inflammatory factors in ventral spinal cord 4.1 (VSC4.1) cells. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glu- tamate (LGA) (24 h), 100 nm melatonin (24 h pretreat- ment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-overexpressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50- overexpressed cells + 25 lm LGA (24 h). (A) Western blot anal- ysis to show levels of ERb, ERa, NF-jB, COX-2, and b-actin. (B) Densitometric analysis showing the ERb: ERa ratio. (C) Bar graphs indicating the changes in the expression of NF-jB and COX-2 over Con.

Article Snippet: After washing with serum-free standard medium (DMEM/F12), motoneurons were transfected in 1% low serum medium [26] over the course of 24 h at 37 C with 35 lL lipofectamine (Life Technologies, Grand Island, NY, USA) and 10 lg of GFP-tagged ORF clone of homosapiens MT1 (MTNR1A: RG210385), MT2 (MTNR1B: RG216445), or GPR50 (RG217839) plasmid (Origene, Rockville, MD, USA).

Techniques: Over Expression, Plasmid Preparation, Expressing, Control, Western Blot

Fig. 4 Overexpression of MT1 and MT2 increases survival and angiogenesic factors in ventral spinal cord 4.1 (VSC4.1) cells. Plas- mid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2– overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h exposure), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h exposure), MT1-overex- pressed cells + 25 lm LGA (24 h), MT2-overexpressed cells + 25 lm LGA (24 h exposure), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h exposure), GPR50-overexpressed cells + 25 lm LGA (24 h exposure). (A) Western blot analysis to show levels of p-Akt, Bcl-2, p-Bad, Flk-1, Flt-1, VEGF, and b-actin. (B) Bar graphs indicating the changes in expression of p-Akt, Bcl-2, and p-Bad over Con. (C) Bar graphs indicating changes in the expression of Flk-1, Flt-1, and VEGF over Con.

Journal: Journal of Pineal Research

Article Title: Overexpression of melatonin membrane receptors increases calcium‐binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms

doi: 10.1111/j.1600-079x.2012.01022.x

Figure Lengend Snippet: Fig. 4 Overexpression of MT1 and MT2 increases survival and angiogenesic factors in ventral spinal cord 4.1 (VSC4.1) cells. Plas- mid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2– overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h exposure), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h exposure), MT1-overex- pressed cells + 25 lm LGA (24 h), MT2-overexpressed cells + 25 lm LGA (24 h exposure), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h exposure), GPR50-overexpressed cells + 25 lm LGA (24 h exposure). (A) Western blot analysis to show levels of p-Akt, Bcl-2, p-Bad, Flk-1, Flt-1, VEGF, and b-actin. (B) Bar graphs indicating the changes in expression of p-Akt, Bcl-2, and p-Bad over Con. (C) Bar graphs indicating changes in the expression of Flk-1, Flt-1, and VEGF over Con.

Article Snippet: After washing with serum-free standard medium (DMEM/F12), motoneurons were transfected in 1% low serum medium [26] over the course of 24 h at 37 C with 35 lL lipofectamine (Life Technologies, Grand Island, NY, USA) and 10 lg of GFP-tagged ORF clone of homosapiens MT1 (MTNR1A: RG210385), MT2 (MTNR1B: RG216445), or GPR50 (RG217839) plasmid (Origene, Rockville, MD, USA).

Techniques: Over Expression, Expressing, Control, Western Blot

Fig. 5. Overexpression of MT1 and MT2 suppresses apoptotic pathways in ventral spinal cord 4.1 (VSC4.1) cells. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-over- expressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50-overexpressed cells + 25 lm LGA (24 h). (A) Western blot analysis to show levels of Bax, Bcl-2, active caspase-9, active caspase-3, and b-actin. (B) Densitometric analysis showing the Bax:Bcl-2 ratio. (C) Bar graphs indicating the changes in expression of active caspase-9 and active caspase-3 over Con. (D) Colorimetric determination of caspase-9 and caspase-3 activities.

Journal: Journal of Pineal Research

Article Title: Overexpression of melatonin membrane receptors increases calcium‐binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms

doi: 10.1111/j.1600-079x.2012.01022.x

Figure Lengend Snippet: Fig. 5. Overexpression of MT1 and MT2 suppresses apoptotic pathways in ventral spinal cord 4.1 (VSC4.1) cells. Plasmid-mediated increase (P›) in expression was shown. Treatment groups: control cells (Con), 100 nm melatonin (24 h pretreatment), MT1-overexpressed cells, MT2-overexpressed cells, MT1 + MT2–overexpressed cells, G-protein receptor 50 (GPR50)-overexpressed cells, 25 lm L-glutamate (LGA) (24 h), 100 nm melatonin (24 h pretreatment) + 25 lm LGA (24 h), MT1-overexpressed cells + 25 lm LGA (24 h), MT2-over- expressed cells + 25 lm LGA (24 h), MT1 + MT2–overexpressed cells + 25 lm LGA (24 h), GPR50-overexpressed cells + 25 lm LGA (24 h). (A) Western blot analysis to show levels of Bax, Bcl-2, active caspase-9, active caspase-3, and b-actin. (B) Densitometric analysis showing the Bax:Bcl-2 ratio. (C) Bar graphs indicating the changes in expression of active caspase-9 and active caspase-3 over Con. (D) Colorimetric determination of caspase-9 and caspase-3 activities.

Article Snippet: After washing with serum-free standard medium (DMEM/F12), motoneurons were transfected in 1% low serum medium [26] over the course of 24 h at 37 C with 35 lL lipofectamine (Life Technologies, Grand Island, NY, USA) and 10 lg of GFP-tagged ORF clone of homosapiens MT1 (MTNR1A: RG210385), MT2 (MTNR1B: RG216445), or GPR50 (RG217839) plasmid (Origene, Rockville, MD, USA).

Techniques: Over Expression, Plasmid Preparation, Expressing, Control, Western Blot

Fig. 6. Silencing MT1 and MT2 enhanced glutamate toxicity in ventral spinal cord 4.1 (VSC4.1) cells. We indicated the use of RNA interference (RNAi) to cause a decrease in expression. Treatment groups: control cells (Con), 25 lm L-glutamate (LGA) (24 h exposure), MT1-silenced cells + 25 lm LGA (24 h exposure); MT2-silenced cells + 25 lm LGA (24 h), MT1 + MT2-silenced cells + 25 lm LGA (24 h exposure); G-protein receptor 50 (GPR50) silenced cells + 25 lm LGA (24 h), 25 lm LGA (24 h), 25 lm LGA + 100 nm melatonin (24 h exposure), MT1-silenced cells + 25 lm LGA+ 100 nm melatonin (24h exposure), MT2 silenced cells + 25 lm LGA + 100 nm melatonin (24 h exposure), MT1 + MT2-silenced cells + 25 lm LGA + 100 nm melatonin (24 h exposure), GPR50 silenced cells + 25 lm LGA + 100 nm melatonin (24 h exposure). (A) Representative pictures showing levels of MT1, MT2, GPR50, and b-actin levels (Western blotting). (B) Bar graphs indicating the percentage of viability (trypan blue dye exclusion test) counted from each group. (C) Colorimetric determination of caspase-3 activity.

Journal: Journal of Pineal Research

Article Title: Overexpression of melatonin membrane receptors increases calcium‐binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms

doi: 10.1111/j.1600-079x.2012.01022.x

Figure Lengend Snippet: Fig. 6. Silencing MT1 and MT2 enhanced glutamate toxicity in ventral spinal cord 4.1 (VSC4.1) cells. We indicated the use of RNA interference (RNAi) to cause a decrease in expression. Treatment groups: control cells (Con), 25 lm L-glutamate (LGA) (24 h exposure), MT1-silenced cells + 25 lm LGA (24 h exposure); MT2-silenced cells + 25 lm LGA (24 h), MT1 + MT2-silenced cells + 25 lm LGA (24 h exposure); G-protein receptor 50 (GPR50) silenced cells + 25 lm LGA (24 h), 25 lm LGA (24 h), 25 lm LGA + 100 nm melatonin (24 h exposure), MT1-silenced cells + 25 lm LGA+ 100 nm melatonin (24h exposure), MT2 silenced cells + 25 lm LGA + 100 nm melatonin (24 h exposure), MT1 + MT2-silenced cells + 25 lm LGA + 100 nm melatonin (24 h exposure), GPR50 silenced cells + 25 lm LGA + 100 nm melatonin (24 h exposure). (A) Representative pictures showing levels of MT1, MT2, GPR50, and b-actin levels (Western blotting). (B) Bar graphs indicating the percentage of viability (trypan blue dye exclusion test) counted from each group. (C) Colorimetric determination of caspase-3 activity.

Article Snippet: After washing with serum-free standard medium (DMEM/F12), motoneurons were transfected in 1% low serum medium [26] over the course of 24 h at 37 C with 35 lL lipofectamine (Life Technologies, Grand Island, NY, USA) and 10 lg of GFP-tagged ORF clone of homosapiens MT1 (MTNR1A: RG210385), MT2 (MTNR1B: RG216445), or GPR50 (RG217839) plasmid (Origene, Rockville, MD, USA).

Techniques: Expressing, Control, Western Blot, Activity Assay